4,019
Views
92
CrossRef citations to date
0
Altmetric
Original Research Articles

Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells

, , , , , , , & show all
Article: 18704 | Received 07 May 2012, Accepted 15 Aug 2012, Published online: 11 Sep 2012

References

  • Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. 2009, 9: 581-93. 10.3402/jev.v1i0.18704.
  • Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. 2007, 9: 654-9. 10.3402/jev.v1i0.18704.
  • Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK, Gho YS. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. 2002, 62: 6312-7.
  • Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi Bet al.Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. 2011, 68: 2667-88. 10.3402/jev.v1i0.18704.
  • Choi DS, Yang JS, Choi EJ, Jang SC, Park S, Kim OYet al.The protein interaction network of extracellular vesicles derived from human colorectal cancer cells. 2012, 11: 1144-51. 10.3402/jev.v1i0.18704.
  • Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina Pet al.Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. 2005, 128: 1796-804. 10.3402/jev.v1i0.18704.
  • Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa Aet al.Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. 2006, 66: 9290-8. 10.3402/jev.v1i0.18704.
  • Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YKet al.Proteomic analysis of microvesicles derived from human colorectal cancer cells. 2007, 6: 4646-55. 10.3402/jev.v1i0.18704.
  • Lee HM, Choi EJ, Kim JH, Kim TD, Kim YK, Kang C, et al.A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells. . 2010;397:251–6. Epub 2010/06/10.10.3402/jev.v1i0.18704.
  • Hong BS, Cho JH, Kim H, Choi EJ, Rho S, Kim Jet al.Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. 2009, 10: 556. 10.3402/jev.v1i0.18704.
  • Xue H, Lu B, Zhang J, Wu M, Huang Q, Wu Qet al.Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. 2010, 9: 545-55. 10.3402/jev.v1i0.18704.
  • Ghosh D, Yu H, Tan XF, Lim TK, Zubaidah RM, Tan HTet al.Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. 2011, 10: 4373-87. 10.3402/jev.v1i0.18704.
  • Lu P, Vogel C, Wang R, Yao X, Marcotte EM. Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. 2007, 25: 117-24. 10.3402/jev.v1i0.18704.
  • Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. 2012, 428: 44-53. 10.3402/jev.v1i0.18704.
  • Bjornson RD, Carriero NJ, Colangelo C, Shifman M, Cheung KH, Miller PLet al.X!!Tandem, an improved method for running X!tandem in parallel on collections of commodity computers. 2008, 7: 293-9. 10.3402/jev.v1i0.18704.
  • Keller A, Eng J, Zhang N, Li XJ, Aebersold R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats. 2005, 1: 2005.0017. 10.3402/jev.v1i0.18704.
  • Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. 2009, 4: 44-57. 10.3402/jev.v1i0.18704.
  • Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SLet al.Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. 2004, 4: 4019-31. 10.3402/jev.v1i0.18704.
  • Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DYet al.Proteomic analysis of microvesicles derived from human colorectal cancer ascites. 2011, 11: 2745-51. 10.3402/jev.v1i0.18704.
  • Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. 2010, 9: 197-208. 10.3402/jev.v1i0.18704.
  • Raimondo F, Morosi L, Chinello C, Magni F, Pitto M. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. 2011, 11: 709-20. 10.3402/jev.v1i0.18704.
  • Roberson CD, Atay S, Gercel-Taylor C, Taylor DD. Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers. 2010, 8: 281-91.
  • Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. 2009, 9: 4997-5000. 10.3402/jev.v1i0.18704.
  • Zhang Y, Ye Y, Shen D, Jiang K, Zhang H, Sun Wet al.Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. 2010, 101: 523-9. 10.3402/jev.v1i0.18704.
  • Buda A, Pignatelli M. Cytoskeletal network in colon cancer: from genes to clinical application. 2004, 36: 759-65. 10.3402/jev.v1i0.18704.
  • Gupta GP, Massague J. Cancer metastasis: building a framework. 2006, 127: 679-95. 10.3402/jev.v1i0.18704.
  • Andre M, Le Caer JP, Greco C, Planchon S, El Nemer W, Boucheix Cet al.Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. 2006, 6: 1437-49. 10.3402/jev.v1i0.18704.
  • Kubens BS, Zanker KS. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). 1998, 131: 55-64. 10.3402/jev.v1i0.18704.
  • Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. 2010, 190: 1079-91. 10.3402/jev.v1i0.18704.
  • Dusek RL, Attardi LD. Desmosomes: new perpetrators in tumour suppression. 2011, 11: 317-23. 10.3402/jev.v1i0.18704.
  • Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. 2010, 11: 556-66. 10.3402/jev.v1i0.18704.
  • Simons M, Raposo G. Exosomes – vesicular carriers for intercellular communication. 2009, 21: 575-81. 10.3402/jev.v1i0.18704.
  • Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Lae Met al.Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. 2007, 67: 6844-53. 10.3402/jev.v1i0.18704.
  • Techasen A, Loilome W, Namwat N, Takahashi E, Sugihara E, Puapairoj Aet al.Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. 2010, 101: 658-65. 10.3402/jev.v1i0.18704.
  • Eswaran J, Soundararajan M, Knapp S. Targeting group II PAKs in cancer and metastasis. 2009, 28: 209-17. 10.3402/jev.v1i0.18704.
  • Chen N, Sun W, Deng X, Hao Y, Chen X, Xing Bet al.Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. 2008, 8: 5108-18. 10.3402/jev.v1i0.18704.
  • Song B, Tang JW, Wang B, Cui XN, Hou L, Sun Let al.Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chip. 2005, 11: 1463-72.
  • Yang HJ, Chen JZ, Zhang WL, Ding YQ.2010, 28: 127-34.
  • Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. Genes that distinguish physiological and pathological angiogenesis. 2007, 11: 539-54. 10.3402/jev.v1i0.18704.
  • O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. 2007, 445: 106-10. 10.3402/jev.v1i0.18704.
  • Halder SK, Anumanthan G, Maddula R, Mann J, Chytil A, Gonzalez ALet al.Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. 2006, 66: 6156-66. 10.3402/jev.v1i0.18704.
  • Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink Det al.Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. 2009, 15: 402-15. 10.3402/jev.v1i0.18704.
  • Mussunoor S, Murray GI. The role of annexins in tumour development and progression. 2008, 216: 131-40. 10.3402/jev.v1i0.18704.
  • Fusco A, Fedele M. Roles of HMGA proteins in cancer. 2007, 7: 899-910. 10.3402/jev.v1i0.18704.
  • Toiyama Y, Inoue Y, Yasuda H, Saigusa S, Yokoe T, Okugawa Yet al.DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness. 2011, 46: 153-63. 10.3402/jev.v1i0.18704.
  • Katoh M. Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. 2003, 22: 1161-8.
  • Zhu XL, Liang L, Ding YQ. Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. 2008, 23: 1041-7. 10.3402/jev.v1i0.18704.
  • Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. 1992, 267: 5700-11.
  • Sawada R, Lowe JB, Fukuda M. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. 1993, 268: 12675-81.
  • Veillette A, Foss FM, Sausville EA, Bolen JB, Rosen N. Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. 1987, 1: 357-74.
  • Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Yet al.Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. 2001, 289: 876-81. 10.3402/jev.v1i0.18704.
  • Stein U, Dahlmann M, Walther W. MACC1 – more than metastasis? Facts and predictions about a novel gene. 2010, 88: 11-8. 10.3402/jev.v1i0.18704.
  • Grade M, Hormann P, Becker S, Hummon AB, Wangsa D, Varma Set al.Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. 2007, 67: 41-56. 10.3402/jev.v1i0.18704.
  • Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi Ret al.Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. 2011, 6: e16636. 10.3402/jev.v1i0.18704.
  • Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man-i M, Ikeda JIet al.Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. 2007, 96: 986-92. 10.3402/jev.v1i0.18704.
  • Roesli C, Borgia B, Schliemann C, Gunthert M, Wunderli-Allenspach H, Giavazzi Ret al.Comparative analysis of the membrane proteome of closely related metastatic and non-metastatic tumor cells. 2009, 69: 5406-14. 10.3402/jev.v1i0.18704.
  • Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XYet al.Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. 2008, 7: 315-25.
  • Zambelli D, Zuntini M, Nardi F, Manara MC, Serra M, Landuzzi Let al.Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). 2010, 126: 41-52. 10.3402/jev.v1i0.18704.
  • Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. 2008, 34: 357-64. 10.3402/jev.v1i0.18704.
  • Komatsu K, Kobune-Fujiwara Y, Andoh A, Ishiguro S, Hunai H, Suzuki Net al.Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. 2000, 83: 769-74. 10.3402/jev.v1i0.18704.
  • Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, Gu Jet al.Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. 2010, 23: 45-52.
  • Beekman JM, Coffer PJ. The ins and outs of syntenin, a multifunctional intracellular adaptor protein. 2008, 121: 1349-55. 10.3402/jev.v1i0.18704.
  • Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. 2006, 5: 219-34. 10.3402/jev.v1i0.18704.
  • Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. 2010, 10: 147-56. 10.3402/jev.v1i0.18704.
  • Ambudkar SV, Sauna ZE, Gottesman MM, Szakacs G. A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1). 2005, 26: 385-7. 10.3402/jev.v1i0.18704.
  • Shi Y, Hu W, Yin F, Sun L, Liu C, Lan Met al.Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). 2004, 7: 160-6. 10.3402/jev.v1i0.18704.
  • Dang DT, Chen F, Kohli M, Rago C, Cummins JM, Dang LH. Glutathione S-transferase pi1 promotes tumorigenicity in HCT116 human colon cancer cells. 2005, 65: 9485-94. 10.3402/jev.v1i0.18704.
  • Wasilenko ST, Stewart TL, Meyers AF, Barry M. Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. 2003, 100: 14345-50. 10.3402/jev.v1i0.18704.